Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL

Talha Munir; Dena Howard; Lucy McParland; Chris Pocock; Andy C. Rawstron; Anna Hockaday; Abraham Varghese; Michael R Hamblin; Adrian Bloor; Andrew R. Pettitt; Chris Fegan; J Blundell; John G. Gribben; David Phillips; Peter Hillmen

doi:10.1038/leu.2017.65

Related publications

Article2012

ELOQUENT-1: A phase III, randomized, open-label trial of lenalidomide/dexamethasone with or without elotuzumab in subjects with previously untreated multiple myeloma (CA204-006).

Meletios A Dimopoulos, Thierry Façon, Paul G. Richardson, Robert Z. Orlowski, Jesús F. San Miguel, Sagar Lonial, Kenneth C. Anderson, Philippe Moreau, Donna Reece, Anil Singhal, Ronald Shazer, Justin Kopit, Antonio Palumbo

Article2022

Randomized phase 3 trial of IO102-IO103 plus pembrolizumab versus pembrolizumab alone in patients with previously untreated, unresectable, or metastatic melanoma.

Inge Marie Svane, Santosh Nair, Igor Puzanov, Caroline Robert, Jessica C. Hassel, Shahneen Sandhu, Anita Vedel Christiansen, Kath Lowery, Kristine Pemberton, Mohammad Al Hajj, Scott J. Diede, E. Ehrnrooth, Alexander M.M. Eggermont

Article2022

EFFECT OF NIFEDIPINE GITS OR RAMIPRIL ON BLOOD PRESSURE VARIABILITY IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTS: RESULTS OF REVERENT RANDOMIZED TRIAL

Grzegorz Bilo, Konsrtantinos Kyriakoulis, Changyuan Liu, Davide Soranna, Isabella Ceravolo, Silvia Cassago, Wei Zhang, Αναστάσιος Κόλλιας, Martino F. Pengo, Antonella Zambon, Ji‐Guang Wang, George S. Stergiou, Gianfranco Parati

Article2023

PS-C12-8: BLOOD PRESSURE VARIABILITY IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTS RANDOMIZED TO NIFEDIPINE GITS OR RAMIPRIL. REVERENT STUDY

Grzegorz Bilo, Konstantinos G. Kyriakoulis, Chang -Yuan Liu, Davide Soranna, Isabella Ceravolo, Silvia Cassago, Wei Zhang, Αναστάσιος Κόλλιας, Martino F. Pengo, Antonella Zambon, Ji‐Guang Wang, George S. Stergiou, Gianfranco Parati

Article2025

Phase 3 study of ivosidenib vs placebo in locally advanced or metastatic IDH1-mutant conventional chondrosarcoma untreated or previously treated with 1 systemic treatment regimen (CHONQUER).

Andrew J. Wagner, Silvia Stacchiotti, C. Debruyne, Abdulazeez Salawu, Jean Yves Blay, Fernando Augusto Batista Campos, Hiroaki Hiraga, Antoine Italiano, Akira Kawai, Ganessan Kichenadasse, Yoshihiro Nishida, Seth M. Pollack, Zhe Qu, Evinaa Sellaiah, Ilona Tala, Gabriel Tinoco, Jonathan C. Trent, Karina Costa Maia Vianna, Kan Yonemori, William D. Tap